Biologics Testing Market Forecast 2025–2034: Where Businesses Should Invest Next

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

#What Is The Projected Market Size Of The Biologics Testing Market By 2029?

The size of the biologics testing market has seen rapid expansion in recent years. This market is projected to increase from $5.92 billion in 2024 to $6.83 billion by 2025, exhibiting a compound annual growth rate (CAGR) of 15.4%. Historically, this growth was influenced by an increase in biologics development, stringent regulatory standards, a focus on quality control in bioprocessing, a rise in biopharmaceutical investments, and the expansion of biomanufacturing capacity.

The biologics testing market is anticipated to experience substantial growth in the coming years. It is projected to achieve a value of $12.84 billion by 2029, with a compound annual growth rate (CAGR) of 17.1%. This expansion during the forecast period is primarily driven by the emergence of advanced therapies, a heightened demand for contract testing services, the expansion of biologics pipelines, the globalization of biopharmaceutical manufacturing, and the increasing need for rapid testing solutions. Noteworthy trends for the forecast period involve advanced analytical technologies, cell-based assays, next-generation sequencing (NGS), the adoption of quality by design (QBD) principles, the integration of artificial intelligence (AI), and efficient methods for product release.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=10276&type=smp

What Are The Main Drivers Boosting The Biologics Testing Industry’s Expansion?

The expansion of the pharmaceutical and biotechnology sectors is projected to drive the biologics testing market’s development. The pharmaceutical industry predominantly concentrates on the creation and production of medicines for various health issues, while the biotechnology industry centers on leveraging technology in biological and medical fields. Biologics testing encompasses examinations to pinpoint and measure impurities, gauge stability, and assess a drug’s immune reaction. This growth in the pharmaceutical and biotechnology industries has also fostered improvements in biologics testing technology, such as the introduction of novel analytical instruments and methods. These advancements have enabled more precise and effective testing, thereby decreasing the duration and expense associated with launching new biologics. For example, in July 2024, Eurostat, a Belgium-based governing body, reported that pharmaceutical production in the EU rose from €36 billion ($39.4 billion) in 2021 to €44 billion ($46.7 billion) in 2023, indicating substantial sector expansion. Consequently, the burgeoning pharmaceutical and biotechnology industries are propelling the growth of the biologics testing market.

Which Key Segments Fueling The Biologics Testing Market?

The biologics testingmarket covered in this report is segmented –

1) By Product: Reagents And Kits; Instruments; Other Products

2) By Test Type: Endotoxin Test; Sterility Test; Mycoplasma Tests; Bioburden Tests; Residual Host-Cell Proteins And DNA Detection Tests; Virus Safety Test; Other Test Types

3) By Application: Vaccine Development And Manufacturing; Monoclonal Antibodies Development And Manufacturing; Cellular And Gene Therapy Products Development And Manufacturing; Blood And Blood Products Development And Manufacturing; Other Applications

Subsegments:

1) By Reagents And Kits: ELISA Kits; PCR Kits; Cell Culture Reagents; Other Assay Kits

2) By Instruments: Spectrophotometers; Chromatography Systems; Microplate Readers; Other Analytical Instruments

3) By Other Products: Software; Consumables; Reference Standards

What Trends Are Redefining The Biologics Testing Market Dynamics?

Product innovations are becoming a significant trend in the biologics testing market. Companies within this market are implementing new, innovative products to uphold their market standing. For instance, in December 2022, Charles River Laboratories International, Inc., a US-based non-clinical contract research organization, unveiled the Endosafe Nexus 200, expanding its extensive endotoxin testing portfolio. The Nexus 200 is a fully robotic instrument, compliant with data integrity standards, marking a further advancement for Charles River. It incorporates Endosafe Limulus Amebocyte Lysate (LAL) cartridge technology and can handle simple or complex serial dilutions for testing water, in-process materials, and final products. Running on Endosafe EndoScan-V version 6.1, the system facilitates data export to a Laboratory Information Management System (LIMS) interface and delivers enhanced traceability, security, and data management via an integrated touch screen.

Which Leading Companies Dominate The Biologics Testing Market Share?

Major companies operating in the biologics testing market include Charles River Laboratories Inc., Thermo Fisher Scientific Inc., Merck KGaA, SGS Société Générale de Surveillance SA, WuXi AppTec Co. Ltd., Sartorius AG, Cytovance Biologics Inc., Pace Analytical Services Inc., Avance Biosciences Inc., Celgene Corporation, Biomerieux SA, Lonza Group Ltd., Genscript Biotech Corp., Bio-Rad Laboratories Inc., Accugen Laboratories Inc., Gibraltar Laboratories Inc., Jordi Labs, Gilead Sciences Inc., Bioquell Limited, Southern Research, Promega Corporation, Lancaster Laboratories Inc., Toxikon Corporation, Eurofins BioPharma Product Testing, Johnson & Johnson Inc., QIAGEN N.V., GlaxoSmithKline plc, Danaher Corporation, Agilent Technologies Inc., PerkinElmer Inc., Abbott Laboratories, Beckman Coulter Inc., Becton Dickinson and Company, Roche Holding AG, Novartis AG, Eli Lilly and Company, Pfizer Inc.

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/biologics-testing-global-market-report

What Regional Growth Trends Are Shaping The Biologics Testing Market Outlook?

North America was the largest region in the biologics testing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the global biologics testing market duirng the forecast period. The regions covered in the biologics testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Request A Customized Version Of The Biologics Testing Market Report:

https://www.thebusinessresearchcompany.com/customise?id=10276&type=smp

Browse Through More Reports Similar to the Global Biologics Testing Market 2025, By The Business Research Company

Tanks Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/tanks-global-market-report

Tank Wagons Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/tank-wagons-global-market-report

Boiler Tank And Shipping Container Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/boiler-tank-and-shipping-container-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795